Pramana, Inc., a leading health technology company, is poised to make a significant impact with its innovative solutions in Digital Pathology 2.0 at the forthcoming USCAP annual conference in Baltimore, MD. The company aims to redefine the landscape of pathology laboratories and revolutionize conventional practices through the application of automation and AI-driven autonomous operations. Pramana’s objective is to effectively address the pressing challenges confronted by laboratories across the United States, including labor shortages and escalating costs.
One of Pramana’s pivotal achievements is the establishment of the world’s largest DICOM repository of whole slide images for anatomic pathology, catering to a diverse range of esteemed clients. This milestone has greatly accelerated digitization initiatives, boasting unrivalled efficiencies that enable laboratories to streamline their daily operations and elevate their diagnostic capabilities.
Pramana’s Chief Product Officer, Prasanth Perugupalli, has highlighted the remarkable progress in whole slide imaging, noting that the company digitizes over 1 million glass slides on a monthly basis for both archival and clinical applications. The collaborative efforts with Image Management System partners have culminated in the creation of the largest DICOM dataset for digital pathology, signifying a new era in the field.
The company’s patented volumetric imaging technology has proven to be a game-changer, particularly in addressing complex areas in pathology such as tissue imaging, microbiology, cytology, and parasitology applications. The implementation of this technology has led to a significant reduction in the overall time and cost of digital operations prior to a pathologist’s review of the image on a computer monitor.
Furthermore, significant advancements in software architecture have empowered Pramana to showcase real-time computation of morphological features on the scanner during the acquisition of high-power images on the glass slide. This breakthrough has facilitated the enhancement of digital images with actionable results without delays, at unprecedented cost efficiencies for the industry, thereby rendering the economics of digital pathology ready for reassessment.
At the USCAP annual conference, Pramana will present two poster presentations that underscore their progress in in-line computation of morphological features, which facilitate actionable outcomes for pathologists.
For individuals seeking further insight into Pramana’s digital pathology solutions, they are encouraged to visit booth #549 at USCAP or schedule a meeting to witness these transformative solutions in action.
In sum, Pramana, Inc. is at the forefront of shaping the future of digital pathology and spearheading the “lab of the future” movement. Their state-of-the-art technologies and visionary approach are poised to revolutionize the industry, and their presence at the upcoming USCAP conference will undoubtedly signify a landmark achievement in the field of pathology.
To discover more about Pramana, Inc. and their innovative solutions, kindly visit their website at www.pramana.ai or connect with them on LinkedIn.